PMID: 19132193Jan 10, 2009Paper

Evaluation of enoxaparin dosing requirements in infants and children. Better dosing to achieve therapeutic levels

Thrombosis and Haemostasis
Mary E BaumanM Patricia Massicotte

Abstract

Increasing the starting dose of enoxaparin results in the early achievement of therapeutic anti-factor Xa levels in children receiving enoxaparin which is critical for effective therapy and the reduction of venipunctures. The aim of this study was: i) to determine the enoxaparin dose required to achieve therapeutic anti-factor Xa levels in infants and children, and ii) to establish whether increasing the starting dose of enoxaparin influenced the time required to reach the therapeutic range and the number of venipunctures required for dose-adjustment, and iii) the radiographic outcome of the thrombosis, where applicable. A retrospective chart review of children who received enoxaparin was carried out at the Stollery Children's Hospital, Edmonton, Alberta, Canada. Patients treated with standard-dose enoxaparin (1.5 mg/kg for children < or =3 months of age, 1.0 mg/kg for children > or =3 months of age), were compared with children who received a higher initial starting dose of enoxaparin (1.7 mg/kg for children > or =3 months of age, 1.2 mg/kg for children > or =3 months of age). Infants <3 months required an enoxaparin dose of 1.83 mg/kg, and those who received an increased initial enoxaparin dose resulted in faster attainment o...Continue Reading

Citations

Sep 3, 2013·Thrombosis Research·Marion K MateosRichard J Cohn
Oct 4, 2013·BMC Veterinary Research·Annika WeigandJustus P Beier
Sep 27, 2018·Journal of Clinical Pharmacology·Alice DamammeOlivia Boyer
Mar 23, 2011·Circulation·Michael R JaffUNKNOWN American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology
Oct 1, 2017·The Annals of Pharmacotherapy·Brady S MoffettDonald Yee
Mar 30, 2010·British Journal of Haematology·Vera IgnjatovicPaul Monagle
Dec 3, 2016·Journal of Perinatology : Official Journal of the California Perinatal Association·J C BohnhoffM Good
Jul 17, 2015·Journal of Perinatology : Official Journal of the California Perinatal Association·R GoldsmithUNKNOWN Thrombosis and Hemostasis in Newborns (THiN) Group
Mar 5, 2010·Cardiology in the Young·Joan Sanchez de ToledoConstantinos Chrysostomou
Jan 30, 2010·Critical Care Medicine·Robert I Parker
Jan 4, 2012·Acta Paediatrica·Mirjana Lulic-BoticaGirija Natarajan
Jun 26, 2013·Clinical Pharmacokinetics·Donald L YeeGuy Young
Jun 6, 2014·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Nathan J SchloemerPeter L Havens
Mar 16, 2017·Frontiers in Pediatrics·Lynn Malec, Guy Young
Mar 6, 2016·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Therese M GigliaJonathan W Byrnes
Feb 15, 2011·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·M E BaumanM P Massicotte
Mar 16, 2017·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Yaser A DiabDilip S Nath
Mar 25, 2020·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Alexander MakatsariyaAlexandra Antonova
Jun 18, 2011·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Angelo C MolinariPaola Giordano
Sep 5, 2014·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Robert I Parker
Mar 13, 2013·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Ankush ChanderUNKNOWN Thrombosis and Hemostasis in Newborns (THiN) Group
Feb 26, 2015·Paediatric Drugs·Connie Law, Leslie Raffini
Jul 19, 2016·International Journal of Laboratory Hematology·P Toulon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
Marianna LeungMary H H Ensom
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
Lela S Fung, Christopher Klockau
Journal of Perinatology : Official Journal of the California Perinatal Association
E Friedrich, A B Hameed
© 2021 Meta ULC. All rights reserved